Bruker Expands Clinical Microbiology and Infection Diagnostics Portfolio
Bruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
Bruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
Clinicians can now use two new biomarker-based assays in combination to determine which patients are at higher risk for poor outcomes.
Mayo Clinic is collaborating with Clarapath to address labor shortages and the increasing volume of tissue specimens in pathology labs.
Verichem Laboratories upgraded its web-based, CLIA-compliant data reduction and test reporting software program.
Researchers in the U.S. and the Netherlands have now used a large dataset to build more accurate cardiovascular risk models.